Life Sciences Manufacturer to Expand in Florida & Add 72 Employees
02/10/2012
CEO Scott Sensenbrenner said the project's scope will include the expansion of lab, office space and production areas. He estimates the investment will exceed $850,000.
The firm also plans to add 72 employees to its current 50-person workforce over the next five years, according to Mark Huey, president and CEO of the EDC of Sarasota County. Those new jobs will include R&D, production, customer service, sales and other similar positions.
Founded in Florida in 1998, Enzymedica researches, develops, manufactures and distributes targeted enzyme supplements made from plant-based enzymes. Its dietary supplements support a wide array of indications, including digestive health, food intolerance, cardiovascular, immune, weight loss and other supportive functions.
"Our new facility, which we hope will be operational by September, is centrally located for the majority of our employees, and provides easy access from Interstate 75," explained Sensenbrenner. "We hope to attract top talent in the region."
The company has qualified for various performance-based incentives, including $216,000 from the state and an equal match from the Sarasota County government.
Most Read
-
-
A Turnkey Approach to Manufacturing Location Decisions
Q2 2021
-
Life Sciences Fueling Construction Demand
Q2 2021
-
2020 Top States for Doing Business Showcase Their Pro-Business Environments
Q3 2020
-
What’s Driving Record Industrial Real Estate Demand
Q1 2021
-
35th Annual Corporate Survey: Effects of Global Pandemic Reflected in Executives’ Site and Facility Plans
Q1 2021
-
In Focus: The Effects of the Pandemic on Industrial Design
Q2 2021